Absci Reports Business Updates and First Quarter 2024 Financial and Operating ResultsGlobeNewsWire • 05/14/24
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?Zacks Investment Research • 04/10/24
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsGlobeNewsWire • 03/21/24
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 03/01/24
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?Zacks Investment Research • 03/01/24
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AIGlobeNewsWire • 02/21/24
Is Absci Corporation (ABSI) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 02/05/24
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug PipelineGlobeNewsWire • 12/20/23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology CandidateGlobeNewsWire • 12/04/23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating ResultsGlobeNewsWire • 11/14/23
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseasesBusiness Wire • 11/14/23
Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan CohenGlobeNewsWire • 09/21/23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating ResultsGlobeNewsWire • 08/14/23
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business OfficerGlobeNewsWire • 08/14/23
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine DevelopmentGlobeNewsWire • 08/10/23